ArticleClinical pharmacology and translational medicine2019

Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease.

Segura-Aguilar et al.PubMed ↗Full text ↗

No numbers read from the abstract.